Print

OTC Marketers of the Moment: Profiles of market-leading OTC companies

Published 27/05/2014

Author: Nicholas Hall Reports

UPDATED with year-end 2013 sales


This report examines in detail some of the biggest and most promising players in the OTC market today. In-depth profiles feature facts, data and analysis, giving readers a full picture of where the companies stand and where they are headed. It includes analysis of the future impact of the GSK-Novartis j-v and Bayer's acquisition of Merck Consumer Care.


Abbott • Bayer (inc. Merck CC) • Boehringer Ingelheim • Genomma • GlaxoSmithKline • Hypermarcas • Johnson & Johnson • Merck KGaA • NBTY • Novartis • PGT Healthcare • Pfizer • Prestige Brands • Reckitt Benckiser • Sanofi • Swisse • Takeda • Taisho • Valeant


The profiles explore strengths and weaknesses, analyse growth and dissect past strategy and future directions. Performance in each major OTC category is assessed, including profiles of flagship brands, as well as a regional breakdown. Also covered are launch activity, A+P successes, switch pipelines and plans for geographic expansion, including details of planned acquisitions or increased investment in particular markets.

A brief description of each company profile is listed below. Alternatively, a full table of contents as well as sample pages are available to download here.

Each company profile includes the following sections:

OVERVIEW
• Nicholas Hall writes • OTC sales • Regional split • Category split • The company in brief        

• Turnover by division

DEVELOPMENT & STRATEGY
• Recent activities • Development milestones (since 2008) • Acquisition strategy                    

• Clouds on the horizon

OTC FOCUS
• Success factors • OTC sales by region • Regional breakdown • Expansion plans • Major OTC category breakdown • OTC sales by category • Top 10 OTC brands
• Flagship brand profiles

• Top 5 OTC brand growth-share matrix • Analysis of individual major OTC categories, with sales and Top 5 brands    




DescriptionCountry LicenceGlobal LicenceBuy Country LicenceBuy Global Licence 
+ Full report (Price includes 50% discount) £5,500.00 £7,000.00 Clear
+ Individual Profiles
+ Abbott (Price includes 50% discount) £400.00 £500.00 Clear
+ Bayer (inc. Merck CC) (Price includes 50% discount) £400.00 £500.00 Clear
+ Boehringer Ingelheim (Price includes 50% discount) £400.00 £500.00 Clear
+ Genomma (Price includes 50% discount) £400.00 £500.00 Clear
+ GlaxoSmithKline (Price includes 50% discount) £400.00 £500.00 Clear
+ Hypermarcas (Price includes 50% discount) £400.00 £500.00 Clear
+ Johnson & Johnson (Price includes 50% discount) £400.00 £500.00 Clear
+ Merck KGaA (Price includes 50% discount) £400.00 £500.00 Clear
+ NBTY (Price includes 50% discount) £400.00 £500.00 Clear
+ Novartis (Price includes 50% discount) £400.00 £500.00 Clear
+ Pfizer (Price includes 50% discount) £400.00 £500.00 Clear
+ PGT Healthcare (Price includes 50% discount) £400.00 £500.00 Clear
+ Prestige Brands (Price includes 50% discount) £400.00 £500.00 Clear
+ Reckitt Benckiser (Price includes 50% discount) £400.00 £500.00 Clear
+ Sanofi (Price includes 50% discount) £400.00 £500.00 Clear
+ Swisse (Price includes 50% discount) £400.00 £500.00 Clear
+ Takeda (Price includes 50% discount) £400.00 £500.00 Clear
+ Taisho (Price includes 50% discount) £400.00 £500.00 Clear
+ Valeant (Price includes 50% discount) £400.00 £500.00 Clear